FDA Nationwide Ergonomic Services
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
FDA OFFICE OF ACQ GRANT SVCS
Contract Value
Not provided
Codes & Classification
Solicitation Number
75F40126Q00019
NAICS
541690 - Other Scientific and Technical Consulting Services
Classification Code
R499
Additional Details
The Food and Drug Administration (FDA), operating under the Department of Health and Human Services (HHS), has issued a combined synopsis/solicitation for the provision of nationwide ergonomic services. This procurement, identified by solicitation number 75F40126Q00019, is structured as a Request for Quotation (RFQ) and represents the agency’s sole solicitation for this requirement; no separate written solicitation will be issued.
The primary objective of this procurement is to secure comprehensive ergonomic services to support FDA operations across the United States. The scope encompasses the delivery of expert consulting and technical services aimed at enhancing workplace ergonomics, thereby promoting employee health, safety, and productivity. While specific deliverables and requirements are detailed in the attached RFQ and amendment documents, contractors can expect to provide a range of ergonomic assessments, recommendations, and potentially implementation support tailored to FDA’s diverse operational environments.
This opportunity is a total set-aside for small business concerns, as defined by the Small Business Administration (SBA). The applicable North American Industry Classification System (NAICS) code is 541690, “Other Scientific and Technical Consulting Services,” with a corresponding small business size standard of $19 million. The Product Service Code (PSC) associated with this requirement is R499, which covers “Other Professional Services.”
The FDA anticipates awarding a single Time-and-Materials (T&M) type Purchase Order as a result of this solicitation. The contract will feature a Base Year, four (4) Option Years, and an additional 6-Month Option to Extend Services in accordance with FAR 52.217-8. The anticipated period of performance is set to commence on March 30, 2026, though the final dates will be confirmed at the time of award.
The principal place of performance is Silver Spring, Maryland, though the “nationwide” scope suggests that services may be required at various FDA locations across the United States. The contracting activity is managed by the FDA Office of Acquisition and Grant Services, a federal office within the Food and Drug Administration.
Interested small business contractors should note that the solicitation has been amended (see RFQ Amendment 0001 and the associated Questions and Answers document), and are encouraged to review all seven attachments available via the SAM.gov opportunity listing for comprehensive details on requirements, evaluation criteria, and submission instructions.
For further information or clarification, prospective offerors may contact the designated contracting officials: Melinda Kim ([email protected]) and Nicholas Bisher ([email protected]).
This procurement represents a significant opportunity for qualified small businesses specializing in scientific and technical consulting services, particularly those with demonstrated expertise in workplace ergonomics. Contractors should ensure their capabilities align with the FDA’s requirements and be prepared to deliver high-quality, responsive ergonomic solutions on a nationwide scale throughout the contract lifecycle.
Documents7